Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

In-Process Control: SOP for Inspection of Filled Syringes before Sealing – V 2.0

Posted on By

In-Process Control: SOP for Inspection of Filled Syringes before Sealing – V 2.0

Standard Operating Procedure for Inspection of Filled Syringes before Sealing


Department In-Process Control
SOP No. SOP/IPC/173/2025
Supersedes SOP/IPC/173/2022
Page No. Page 1 of 14
Issue Date 24/06/2025
Effective Date 25/06/2025
Review Date 24/06/2026

1. Purpose

To define the procedure for inspecting filled syringes before sealing to ensure compliance with quality standards, detect defects, and maintain sterility and product integrity in aseptic manufacturing operations.

2. Scope

This SOP applies to all prefilled syringe batches manufactured at [Insert

Company Name], specifically during the inspection phase prior to plunger rod insertion and final sealing.

3. Responsibilities

  • Production Operator: To perform real-time visual inspection of filled syringes on the conveyor belt and segregate defectives.
  • IPQA Officer: To perform periodic inspection checks, confirm reject categorization, and maintain inspection records.
  • Production Supervisor: To ensure line setup is correct and that trained personnel are deployed for inspection.
  • Quality Assurance Manager: To review inspection reports and approve batch progression to sealing.

4. Accountability

The Head of Quality Assurance is accountable for the overall compliance with the inspection protocol and verification of inspection documentation.

See also  Sterile Injectable Manufacturing: SOP for Labeling of Dispensed Materials - V 2.0

5. Procedure

5.1 Pre-Inspection Setup

  1. Ensure the inspection station is clean, sterile, and equipped with adequate illumination (1000–2000 Lux) and a black & white background panel.
  2. Verify that all visual inspection personnel are trained and qualified with current validation records.
  3. Review the batch manufacturing record (BMR) and confirm that filling operations are complete and in-process checks passed.
  4. Ensure protective wear and gowning are as per aseptic guidelines.

5.2 Visual Inspection Process

  1. Inspect each filled syringe for the following defects:
    • Presence of particles (fibers, glass, or rubber)
    • Air bubbles beyond allowable limits
    • Volume inconsistency
    • Discoloration or layering of solution
    • Plunger displacement or leakage
    • Damaged or misaligned syringe barrels
  2. Rotate each syringe 360° against black and white backgrounds while gently inverting to detect floating or visible particles.
  3. Reject syringes that fail to meet visual acceptance criteria and place them into the designated “Rejected Syringes Bin.”
  4. Every 30 minutes, document the number of inspected and rejected syringes in the Inspection Log Sheet (Annexure-1).

5.3 Sampling and IPQA Verification

  1. IPQA must verify 1% of the total inspected syringes every hour, randomly selected.
  2. Cross-check for:
    • Volume variation using calibrated volumetric devices
    • Particle presence using reference visual guides
    • Compliance with defined acceptance quality limits (AQL)
  3. Document the observations in the IPQA Verification Record (Annexure-2).
See also  Manufacturing Operations: SOP for Inert Gas Purging during Injectable Manufacturing - V 2.0

5.4 Defect Classification

Defects are classified as:

  • Critical: Glass particles, microbial contamination, leakage – reject entire batch if trend observed.
  • Major: Volume deviation, plunger misalignment – require 100% inspection of the batch.
  • Minor: Cosmetic issues not impacting quality (e.g., minor scratches).

5.5 Handling of Rejections

  1. Rejected syringes must be:
    • Documented with reason
    • Cross-verified by IPQA
    • Moved to a segregated and labeled container with “Rejected Syringes – Hold for Destruction” label
  2. Ensure reconciliation of filled vs. rejected vs. sealed quantities post inspection.

5.6 Documentation and Batch Clearance

  1. Upon completion of inspection, Production and QA must jointly:
    • Review inspection log sheets
    • Confirm acceptance limits are met
    • Approve continuation to the sealing stage
  2. Attach inspection summary report to the BMR and retain records as per data integrity policy.

5.7 Line Clearance

  1. After inspection and before sealing, IPQA must:
    • Perform line clearance
    • Ensure no rejected syringes are mixed with acceptable units
    • Confirm environmental monitoring results are within limits
  2. Document line clearance in the Line Clearance Form (Annexure-3).
See also  Sterile Injectable Manufacturing: SOP for Ensuring Compliance with GMP in Machine Operations - V 2.0

6. Abbreviations

  • SOP: Standard Operating Procedure
  • IPQA: In-Process Quality Assurance
  • AQL: Acceptance Quality Limit
  • BMR: Batch Manufacturing Record

7. Documents

  1. Inspection Log Sheet – Annexure-1
  2. IPQA Verification Record – Annexure-2
  3. Line Clearance Form – Annexure-3

8. References

  • WHO GMP Guidelines for Sterile Pharmaceutical Products
  • EU GMP Annex 1 – Manufacture of Sterile Medicinal Products
  • 21 CFR Part 211.110 – Sampling and Testing of In-Process Materials

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Production Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Inspection Log Sheet

Date Batch No. Time No. Inspected No. Rejected Inspector
24/06/2025 SYN0625-02 10:00 AM 200 3 Rajesh Kumar

Annexure-2: IPQA Verification Record

Date Batch No. Sample Size Defects Found Result Checked By
24/06/2025 SYN0625-02 10 None Compliant Sunita Reddy

Annexure-3: Line Clearance Form

Date Batch No. Area Inspector Clearance Time Remarks
24/06/2025 SYN0625-02 Inspection Zone Sunita Reddy 12:30 PM Clean

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Release New SOP QA Head
24/06/2025 2.0 Updated with annexures and AQL classification Periodic Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Analytical Method Development: SOP for Impurity Analysis in Nasal Formulations – V 2.0
Next Post: Using Microlearning Tools for SOP Awareness

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version